Intraluminal medical device with nested interlocking segments
CA 2833491 C · Owner: Nitinol Development Corporation · Inventors: Bonsignore, Craig
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
An intraluminal medical device having nested interlocking axially adjacent segments that remain interlocked during delivery to an intended treatment site is preferably a stent in which the nested interlocked axially adjacent segments provide increased control and stability of the stent during delivery and increased vessel support when full deployment is effected. A series of repeating cells comprise a segment. Each cell comprises a protrusion and a radially and circumferentially adjacent receptacle. The protrusion from at least one cell in a segment interlocks with the receptacle of an axially adjacent segment to form the stent. The protrusions remain coupled with a corresponding receptacle …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed September 27, 2006 and granted December 15, 2015. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended September 27, 2026.
- Certificates of supplementary protection extend only drug patents, and it isn't classified as one.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.